Education
About Us
Working with TipRanks
Follow Us
Oncology Institute, Inc. (TOI)
NASDAQ:TOI
Total Valuation
Oncology Institute has a market cap or net worth of $280.70M. The enterprise value is $272.13M.
Market Cap$280.70M
Enterprise Value$272.13M
Share Statistics
Oncology Institute has 98,381,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98,381,340
Owned by Insiders13.09%
Owned by Institutions7.56%
Financial Efficiency
Oncology Institute’s return on equity (ROE) is 3.86 and return on invested capital (ROIC) is -35.70%.
Return on Equity (ROE)3.86
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-35.70%
Return on Capital Employed (ROCE)-0.39
Revenue Per Employee609.37K
Profits Per Employee-73.46K
Employee Count825
Asset Turnover3.05
Inventory Turnover25.67
Valuation Ratios
The current PE Ratio of Oncology Institute is ―. Oncology Institute’s PEG ratio is 2.27.
PE Ratio―
PS Ratio6.54
PB Ratio-209.23
Price to Fair Value-209.23
Price to FCF-118.37
Price to Operating Cash Flow-194.90
PEG Ratio2.27
Income Statement
In the last 12 months, Oncology Institute had revenue of 502.73M and earned -60.61M in profits. Earnings per share was -0.54.
Revenue502.73M
Gross Profit0.00
Operating Income-36.08M
Pretax Income-60.74M
Net Income-60.61M
EBITDA-42.52M
Earnings Per Share (EPS)-0.54
Cash Flow
In the last 12 months, operating cash flow was -14.78M and capital expenditures -2.00M, giving a free cash flow of -16.78M billion.
Operating Cash Flow-14.78M
Free Cash Flow-16.78M
Free Cash Flow per Share-0.17
Dividends & Yields
Oncology Institute pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.56
52-Week Price Change305.71%
50-Day Moving Average3.03
200-Day Moving Average3.33
Relative Strength Index (RSI)51.29
Average Volume (3m)1.58M
Important Dates
Oncology Institute upcoming earnings date is May 13, 2026, After Close (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Oncology Institute as a current ratio of 1.59, with Debt / Equity ratio of -167.22%
Current Ratio1.59
Quick Ratio1.35
Debt to Market Cap<0.01
Net Debt to EBITDA0.25
Interest Coverage Ratio-3.20
Taxes
In the past 12 months, Oncology Institute has paid -131.00K in taxes.
Income Tax-131.00K
Effective Tax Rate<0.01
Enterprise Valuation
Oncology Institute EV to EBITDA ratio is -112.63, with an EV/FCF ratio of -118.11.
EV to Sales6.53
EV to EBITDA-112.63
EV to Free Cash Flow-118.11
EV to Operating Cash Flow-133.48
Balance Sheet
Oncology Institute has $33.56M in cash and marketable securities with $26.29M in debt, giving a net cash position of $7.28M billion.
Cash & Marketable Securities$33.56M
Total Debt$26.29M
Net Cash$7.28M
Net Cash Per Share$0.07
Tangible Book Value Per Share-$0.04
Margins
Gross margin is 13.82%, with operating margin of -7.18%, and net profit margin of -12.06%.
Gross Margin13.82%
Operating Margin-7.18%
Pretax Margin-12.08%
Net Profit Margin-12.06%
EBITDA Margin-5.80%
EBIT Margin-7.18%
Analyst Forecast
The average price target for Oncology Institute is $7.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.00
Price Target Upside81.82% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast21.67%
EPS Growth Forecast16.74%